Allergan begins trials on hair-growth drug
Drugmaker Allergan is recruiting volunteers for clinical trials of a hair-growth treatment based on the active ingredient in Latisse (bimatoprost ophthalmic solution, 0.03 percent), the company’s eyelash-growth treatment.
Read more:
Allergan begins trials on hair-growth drug
Glaucoma eye drops drug Latisse used OTC to make long eyelashes but some now face side effects
From the NYTimes:Latisse is the same formula as Lumigan, Allergan’s eyedrops for glaucoma, which reduces eye pressure but also happens to grow lashes. Both are also known as bimatoprost ophthalmic solution. In early 2009, Allergan introduced the drug as a lash enhancer.A former primary care doctor runs www.latisse.bz, which boasts that it is the “largest Latisse retailer.� All it takes to get Latisse mailed out — without ever seeing him — is filling out a medical history, which he reviews, and typing in a valid credit card number.But if people use Latisse without seeing a doctor, the side effects may come as a big surprise.Eyelid discoloration “may be reversible� according to the manufacturer
Read the original:
Glaucoma eye drops drug Latisse used OTC to make long eyelashes but some now face side effects
Latisse Faces Patent Challenge
The FDA said a company is challenging Allergan’s patent protection for the eyelash drug Latisse, looking to make a generic version. (Source: WSJ.com: Health)
Read more from the original source:
Latisse Faces Patent Challenge
From Serendipity to Pilot Study and Then Pivotal Trial: Bimatoprost Topical for Eyelash Growth
Dr. Cohen has been a consultant and clinical trial investigator for Allergan (including related to Latisse). (Source: Dermatologic Surgery)
Link:
From Serendipity to Pilot Study and Then Pivotal Trial: Bimatoprost Topical for Eyelash Growth
Policy & Practice
Can’t get enough Policy & Practice? Check out our new podcast each Monday
Read more:
Policy & Practice
FDA: Allergan’s Web Site Is Misleading
The FDA said the Web site of Allergan’s Latisse is misleading because it suggests the company’s eyelash thickener is more safe than proven. (Source: WSJ.com: Health)
Go here to see the original:
FDA: Allergan’s Web Site Is Misleading
Allergan Gets Nod For Eyelash Treatment
Eye care and cosmetic drug maker Allergan on Friday said its eyelash growth treatment Latisse received Food and Drug Administration approval,… (Source: Investor’s Business Daily: HEALTH)
Original post:
Allergan Gets Nod For Eyelash Treatment
Epione Beverly Hills- Treatment For Sun Damaged Skin
- Breast Plastic Surgery – Symmetry, Form and Beauty
- Facial Acne Scars: Erasing The Marks Of Your Youth
- Danielle Staub from the Real Housewives of New Jersey receives Botox treatment at Epione Beverly Hills
- Do You Hate Your Acne Scars?
- The return of perfect skin
- Would You Like To Get Fuller Lips?
- Facial Wrinkle Removal: Getting Rid Of Facial Wrinkles
- Acne Scars: Information About Reducing The Appearance Of Acne Scars
- Cellulite Removal: Know The Facts